Arabadjief, Melissa A.
Elsayed, Omar H.
Bashir, Sabina
Gundumalla, Meenakshi R.
Menefee, Derek S.
Bergman, Cody L.
Moulana, Nayeem Z.
El-Mallakh, Rif S.
Article History
Received: 16 April 2022
Accepted: 13 May 2022
First Online: 7 July 2022
Declarations
:
: Our institutional human subjects protection program allowed submission of this case presentation (IRB number 22.1081). Written informed consent was obtained from the patient for publication of this case report and any accompanying images. A copy of the written consent is available for review by the Editor-in-Chief of this journal.
: Written informed consent was obtained from the patient for publication of this case report and any accompanying images. A copy of the written consent is available for review by the Editor-in-Chief of this journal.
: There are no actual competing interests for this paper. However, Dr. El-Mallakh serves as a speaker for Indivior, Intracellular Therapies, Janssen, Lundbeck, Noven, Otsuka, Sunovion, and Teva. None of the other authors has any actual or perceived competing interests.